Xianliang Yan

Xianliang Yan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Theranostics
Verified
Journal Article
Open access
XZXuemei Zong
Xuemei Zong
YLYuyu Li
Yuyu Li
CLCui Liu
Cui Liu
WQWenxuan Qi
Wenxuan Qi
DHDong Han
Dong Han
QZQuanguang Zhang
Quanguang Zhang
Rationale: The integrity and function of the blood-brain barrier (BBB) is compromised after stroke. The current study was performed to examine potential beneficial effects and underlying mechanisms of repetitive transcranial magnetic stimulation (rTMS) on angiogenesis and vascular protection, function, and repair following stroke, which are largely unknown.

15 September 2017 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
TLTan Li
Tan Li
YZYong-Mei Zhang
Yong-Mei Zhang
DHDong Han
Dong Han
RHRong Hua
Rong Hua
BGBing-Nan Guo
Bing-Nan Guo
TXTie Xu
Tie Xu

25 June 2025 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
MZMengmeng Zhang
Mengmeng Zhang
BGBingnan Guo
Bingnan Guo
XZXiaowei Zhang
Xiaowei Zhang
DHDong Han
Dong Han
LLLanxin Lv
Lanxin Lv
SHShuqun Hu
Shuqun Hu
Acute ischemic stroke is a disastrous disease characterized by damaging blood flow in the brain, leading to acute brain injury. Acute brain ischemia elicits severe inflammation, thus in turn, aggravates neural injury. Interferon-Induced Protein 35 (IFP35), is a 35 kDa protein, a novel type of DAMP that trigger inflammatory responses, exacerbating acute and chronic inflammatory disease. This study aimed to investigate the potential neuroinflammation role of IFP35 in acute ischemic stroke in a mouse model of MCAO. C57BL/6 male mice were subjected to middle cerebral artery occlusion (MCAO) to establish an animal model of acute ischemic stroke. Leveraging serum from stroke patients, serum and brain tissue after MCAO mice, IFP35 was released. Immunofluorescence assay was used to investigated the cell sources of IFP35 expression after MCAO. The impact of IFP35 on neuroinflammation and neural injury was assessed by siRNA-mediated cerebral IFP35 knockdown. Behavioral tests, and brain tissues were harvested for histological analysis and biochemical assays. TUNEL assays were used to evaluate neuronal damage. TTC staining was performed to assess infarction volumes. Additionally, using western blotting and immunofluorescence assays, we further assessed the contribution of TLR4/NF-κB/NLRP3 signaling in MCAO mice and BV2 cells. IFP35 was accumulated in peripheral blood of cerebral ischaemia patients, ischemia mice serum, as well as peri-infarct regions in focal cerebral ischemia mice. Although endothelial cells, microglia, and astrocytes are capable of expressing IFP35, cerebral neural cells seem to express and release more IFP35 compare to other cell types. Knockdown of IFP35 alleviated the production of neuroinflammatory cytokines, decreased neuronal death, and minimized infarct volumes, ultimately leading to improved neurological outcomes. Importantly, IFP35 triggered the activation of NF-κΒ and NLRP3 signaling, exacerbating neuroinflammation and brain injury by binding its receptor TLR4. This study revealed IFP35 as a novel DAMP released during cerebral ischemia that promotes neuroinflammation and injury, expanding the current understanding of inflammatory networks following stroke.

1 December 2017 in Brain Research
Verified
Journal Article
Closed access
XZXuemei Zong
Xuemei Zong
SWShuguang Wu
Shuguang Wu
FLFujun Li
Fujun Li
LLLanxin Lv
Lanxin Lv
DHDong Han
Dong Han
TXTie Xu
Tie Xu

28 October 2019 in Journal of Biophotonics
Verified
Journal Article
Closed access
PDF file
BYBaocheng Yang
Baocheng Yang
JXJuanyong Xu
Juanyong Xu
YLYong Li
Yong Li
YDYan Dong
Yan Dong
YLYuyu Li
Yuyu Li
XYXianliang Yan
Xianliang Yan

7 April 2016 in Scientific Reports
Verified
Journal Article
Open access
DZDengyue Zhang
Dengyue Zhang
NZNingjun Zhao
Ningjun Zhao
BMBin Ma
Bin Ma
YWYan Wang
Yan Wang
GZGongliang Zhang
Gongliang Zhang
TXTie Xu
Tie Xu
Transnitrosylation is an important mechanism by which nitric oxide (NO) modulates cell signaling pathways. For instance, SNO-caspase-3 can transnitrosylate the X-linked inhibitor of apoptosis (XIAP) to enhance apoptosis. XIAP is a potent antagonist of caspase apoptotic activity. Decrease in XIAP activity via nitrosylation results in SNO-XIAP-mediated caspase activation. Considering the functional liaison of procaspase-9 and XIAP, we hypothesized that procaspase-9 nitrosylates XIAP directly. Our data confirmed that cerebral ischemia-reperfusion induced XIAP nitrosylation, procaspase-9 denitrosylation and cleavage. Interestingly, the time courses of the nitrosylation of procaspase-9 and XIAP were negatively correlated, which was more prominent after cerebral ischemia-reperfusion, suggesting a direct interaction. The nitrosylation of XIAP, as well as the denitrosylation and cleavage of procaspase-9, were inhibited by DNCB, TrxR1 AS-ODNs, or TAT-AVPY treatment. Meanwhile, DNCB, TrxR1 AS-ODNs, or TAT-AVPY also inhibited the decrease in hippocampal CA1 neurons induced by ischemia-reperfusion in rats. The denitrosylation and cleavage of procaspase-9 induced by OGD/reoxygenation in SH-SY5Y cells were inhibited when cells were co-transfected with wild-type procaspase-9 and XIAP mutant (C449G). These data suggest that cerebral ischemia-reperfusion induces a transnitrosylation from procaspase-9 to XIAP via the Trx system to consequently cause apoptosis. Additionally, Cys325 is a critical S-nitrosylation site of procaspase-9.